Red Capital
Venture capitalTokyo · Seed · 3 people tracked
Also known as Red Capital株式会社
Find your way into Red Capital
Sign up to see every warm intro you have to Red Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Red Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Red Capital is a healthcare-focused venture capital firm that combines two investment approaches: a 'seed-drive' model accompanying companies from the seed stage through exit, and an 'ecosystem-complementary' model that supports growth through secondary investments. Rather than simply providing capital, the firm aims to offer tailored, long-term support appropriate to each growth phase. It focuses on translating scientific breakthroughs in medicine and life sciences into real-world impact, partnering with ambitious entrepreneurs and researchers to help build a better future through the power of technology and science.
Source: firm website, verified Nov 1, 2026.
Team · 3 people
from the firm's websiteCo-founder and Managing Partner of Red Capital, born in New Jersey, USA. She began her career at Bank of Tokyo-Mitsubishi, worked at Tokyo Marine Capital (now T Capital Partners), then joined INCJ where she helped launch a medical-device-focused VC and ran seed-to-early-stage investments in Japan and Silicon Valley. From 2018 she led global investments as head of Omron Ventures for six years, and has been active in training medical innovators. She holds an MBA from Wharton and a PhD in biomedical science.
Co-founder and Managing Partner of Red Capital. After graduate research in biochemistry she became a venture capitalist, spending 18 years at deeptech-focused VC UTEC investing in university-originated startups, primarily in biotech and healthcare. She was involved early with PeptiDream and supported it through IPO, and has served on committees for Japan's METI, MEXT, and Cabinet Office. She holds a PhD in science from the University of Tokyo.
Serves as an outside director of Red Capital.
What they invest in
from 2 of 2 portfolio companiesDigital Health ×2AI & Machine Learning ×1Biotech ×1Data & Infrastructure ×1Deep Tech ×1Healthtech ×1Longevity ×1Medical Devices ×1
HQs:Japan×2
Investments · 2 tracked
founders shown can be your intro pathNeusignal Therapeutics develops novel drugs for central nervous system disorders, including dementia and psychiatric conditions, with research focused on calcium signaling in neurons and target discovery for brain diseases.
BiotechDeep TechDigital HealthMedical DevicesTokyo, JP
有本 達(代表取締役社長CEO)in森口 茂樹(創業科学者/特別顧問)
Co-investorsAngel Bridge Co.,Ltd.Fast Track InitiativeKeio Innovation InitiativeNippon Venture CapitalThe Gogin Capital
Rehab for JAPAN develops and provides "Rehab Cloud," a SaaS platform for elderly care and rehabilitation providers, along with "Rehab Studio," an online rehabilitation service, and conducts R&D on AI-based care technology.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechLongevitySaaSTokyo, JP
大久保亮(代表取締役社長 CEO)in
Co-investorsCapital Medica VenturesEISAI CO.,LTDMitsubishi UFJ CapitalMonex VenturesMTG VenturesNissay Capital+5 more
Frequently asked questions
- What stage does Red Capital invest at?
- Red Capital invests at the Seed stage.
- What sectors does Red Capital focus on?
- Red Capital focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices, Robotics, Sector Agnostic.
- Where is Red Capital located?
- Red Capital is headquartered in Tokyo, JP.
Images
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Menlo Ventures is an early-stage venture capital firm backing transformative technology companies, with a strong current emphasis on artificial intelligence across enterprise, healthcare, and consumer markets.
